Amarin Corp Plc (AMRN)

[The Irishman]

Couldbebetter...there is a great deal of common sense in your post. Even though there is time, the clock is ticking. The insight from the retired Pfizer guy is accurate. So much must be considered here.

Physician education - negative bias towards fish oil. Unfortunately Vascepa has to deal with that stereotype. Requires a full-court press using all of the major institutions and societies that now consider Vascepa as part of their standard of care.

Managed care - this requires a “crack team” with solid relationships to get in the door to sell the savings in overall patient care. The patient benefit and cost savings to the system are there. However, it requires an effective voice to get managed care to listen and to see the light

An effective sales force presence: many bodies in the field making effective sales calls on the right targets with the right amount of frequency. The message must make the case as it relates saving lives. The drug for as great as it is will not sell itself at first. It will require outstanding dialogue between the clinician and the rep. The sales message must be solid! Having said that, this area can be “the Achilles heal”. Too many reps in the field not selling, just dropping off samples tend to waste the time of the doctor. No value.

If Amarin decides to GIA, then they must master all three. They must be all over it now. This isn’t easy to do or create from scratch. Let alone attempt this in Europe. Dear a Lord, what a massive undertaking. In my view, someone else must execute Europe

In my opinion, based on my experience, you only have one shot at executing a great launch.

Which begs the question: What is the best course of action?